← back to search

Hao Li

Tongji University · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer-related molecular mechanisms research, Circular RNAs in diseases, MicroRNA in disease regulation, and RNA modifications and cancer.
h-index
27
citations
2,249
works
104
NIH funding
primary concept
email

Recent publications

Development and validation of a clinical prediction model for osteoporosis diagnosis by lumbosacral X-ray and radiomics
Frontiers in Aging 2025cited by 2position: middledoi
Exosomal U2AF2 derived from human bone marrow mesenchymal stem cells attenuates the intervertebral disc degeneration through circ_0036763/miR-583/ACAN axis
Regenerative Therapy 2024cited by 9position: middledoi
Circular RNAs: Emerging regulators of glucose metabolism in cancer
Cancer Letters 2022cited by 31position: middledoi
Regulatory patterns analysis of transcription factor binding site clustered regions and identification of key genes in endometrial cancer
Computational and Structural Biotechnology Journal 2022cited by 4position: middledoi
Exosomal miR-101-3p and miR-423-5p inhibit medulloblastoma tumorigenesis through targeting FOXP4 and EZH2
Cell Death and Differentiation 2021cited by 86position: middledoi
Exosomal miR-130b-3p targets SIK1 to inhibit medulloblastoma tumorigenesis
Cell Death and Disease 2020cited by 48position: middledoi
Identification and Validation of Novel Long Non-coding RNA Biomarkers for Early Diagnosis of Oral Squamous Cell Carcinoma
Frontiers in Bioengineering and Biotechnology 2020cited by 34position: lastdoi
Cardio-renal Exosomes in Myocardial Infarction Serum Regulate Proangiogenic Paracrine Signaling in Adipose Mesenchymal Stem Cells
Theranostics 2019cited by 79position: middledoi
Coronary Serum Exosomes Derived from Patients with Myocardial Ischemia Regulate Angiogenesis through the miR-939-mediated Nitric Oxide Signaling Pathway
Theranostics 2018cited by 139position: firstdoi
miR‐137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6
FEBS Letters 2012cited by 164position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xiaofeng Chen · East China University of Science and Technology2 papers (2024–2025)Jincheng Liu · Guangzhou University of Chinese Medicine2 papers (2024–2025)Wenxuan Dong · Guangzhou University of Chinese Medicine2 papers (2024–2025)Junxian Xie · Guangzhou University of Chinese Medicine2 papers (2024–2025) · 2 papers (2024–2025)Weijun Guo · Anhui Medical University2 papers (2024–2025)Ping Xue · Second Affiliated Hospital of Guangzhou Medical University2 papers (2020–2021)Saihua Huang · Fudan University2 papers (2020–2021)Caiyan Zhang · Yulin University2 papers (2020–2021)Jinrong Fu · Fudan University2 papers (2020–2021) · 2 papers (2018–2019)Xiao Han · Fudan University2 papers (2020–2021)Lei Gao · Jiangxi University of Traditional Chinese Medicine2 papers (2018–2019)Jinjun Liang · Guangzhou University of Chinese Medicine2 papers (2024–2025)Yufeng Zhou · Southeast University2 papers (2020–2021)Hongming Zhu · Fudan University2 papers (2018–2019)Dongling Cai · Guangzhou University of Chinese Medicine2 papers (2024–2025)Qianqian Li · Nanchang University1 papers (2022–2022)Yue Li · TUM Klinikum1 papers (2020–2020)Xiang Wang · University of Science and Technology of China1 papers (2020–2020)